Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanobiotechnology-assisted therapies to manage brain cancer in personalized manner
Monika Nehra, U.T. Uthappa, Virendra Kumar, et al.
Journal of Controlled Release (2021) Vol. 338, pp. 224-243
Closed Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

An Insight to Brain Targeting Utilizing Polymeric Nanoparticles: Effective Treatment Modalities for Neurological Disorders and Brain Tumor
Annu, Ali Sartaj, Zufika Qamar, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 67
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 56
Tailored Drug Delivery Platforms: Stimulus‐Responsive Core–Shell Structured Nanocarriers
Yulong Shi, Yiran Zhang, Liangliang Zhu, et al.
Advanced Healthcare Materials (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 44
Emergence and impact of theranostic‐nanoformulation of triple therapeutics for combination cancer therapy
Amit Kumar Rajora, Eknath D. Ahire, Manju A. K. Rajora, et al.
Smart Medicine (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 16
Using Graphene-Based Biosensors to Detect Dopamine for Efficient Parkinson’s Disease Diagnostics
Małgorzata Kujawska, Sheetal K. Bhardwaj, Yogendra Kumar Mishra, et al.
Biosensors (2021) Vol. 11, Iss. 11, pp. 433-433
Open Access | Times Cited: 57
Borophene as an emerging 2D flatland for biomedical applications: current challenges and future prospects
Shalu Yadav, Mohd. Abubakar Sadique, Ajeet Kaushik, et al.
Journal of Materials Chemistry B (2022) Vol. 10, Iss. 8, pp. 1146-1175
Closed Access | Times Cited: 57
Nanotechnology-Assisted Metered-Dose Inhalers (MDIs) for High-Performance Pulmonary Drug Delivery Applications
Raj Kumar, Piyush Mehta, K. Ravi Shankar, et al.
Pharmaceutical Research (2022) Vol. 39, Iss. 11, pp. 2831-2855
Open Access | Times Cited: 50
Exploring nano-enabled CRISPR-Cas-powered strategies for efficient diagnostics and treatment of infectious diseases
Ankit Kumar Dubey, Vijai Kumar Gupta, Małgorzata Kujawska, et al.
Journal of nanostructure in chemistry (2022) Vol. 12, Iss. 5, pp. 833-864
Open Access | Times Cited: 49
Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment
Nikhil Pandey, Pavlos Anastasiadis, Christine P. Carney, et al.
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114415-114415
Open Access | Times Cited: 39
Nanotechnology-based drug delivery for the treatment of CNS disorders
Khushi Mittal, Nandini Pharasi, Bhavya Sarna, et al.
Translational Neuroscience (2022) Vol. 13, Iss. 1, pp. 527-546
Open Access | Times Cited: 38
Metal–Organic Frameworks‐Based Nanoplatforms for the Theranostic Applications of Neurological Diseases
Huicong Niu, Hui Bu, Jing Zhao, et al.
Small (2023) Vol. 19, Iss. 23
Closed Access | Times Cited: 35
Nanozyme-based strategies for efficient theranostics of brain diseases
Ran Xu, Sijie Zhang, Peixia Wang, et al.
Coordination Chemistry Reviews (2023) Vol. 501, pp. 215519-215519
Closed Access | Times Cited: 32
Overview of therapeutic drug monitoring and clinical practice
Zijun Fang, He Zhang, Jiuchuan Guo, et al.
Talanta (2023) Vol. 266, pp. 124996-124996
Closed Access | Times Cited: 29
How Precise are Nanomedicines in Overcoming the Blood–Brain Barrier? A Comprehensive Review of the Literature
Priyadarshini Mohapatra, Mohanraj Gopikrishnan, C. George Priya Doss, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2441-2467
Open Access | Times Cited: 11
Brain Delivery of Biomimetic Phosphorus Dendrimer/Antibody Nanocomplexes for Enhanced Glioma Immunotherapy via Immune Modulation of T Cells and Natural Killer Cells
Yamin Peng, Mengsi Zhan, Andrii Karpus, et al.
ACS Nano (2024) Vol. 18, Iss. 14, pp. 10142-10155
Closed Access | Times Cited: 11
Advances in Intrathecal Nanoparticle Delivery: Targeting the Blood–Cerebrospinal Fluid Barrier for Enhanced CNS Drug Delivery
Ahmad Khalid Madadi, Moon‐Jun Sohn
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1070-1070
Open Access | Times Cited: 7
Lanthanide-Doped Upconversion Luminescent Nanoparticles—Evolving Role in Bioimaging, Biosensing, and Drug Delivery
Palak Jethva, Munira Momin, Tabassum Khan, et al.
Materials (2022) Vol. 15, Iss. 7, pp. 2374-2374
Open Access | Times Cited: 31
RETRACTED: QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics
Deepshi Arora, Shailendra Bhatt, Manish Kumar, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 27
Nanobiotechnology-based treatment strategies for malignant relapsed glioma
Qiujun Qiu, Xinyi Ding, Jixiang Chen, et al.
Journal of Controlled Release (2023) Vol. 358, pp. 681-705
Closed Access | Times Cited: 18
Layered double hydroxides and their tailored hybrids/composites: Progressive trends for delivery of natural/synthetic-drug/cosmetic biomolecules
Sonika Kumari, Varruchi Sharma, Savita Soni, et al.
Environmental Research (2023) Vol. 238, pp. 117171-117171
Closed Access | Times Cited: 17
Liposome-Derived Nanosystems for the Treatment of Behavioral and Neurodegenerative Diseases: The Promise of Niosomes, Transfersomes, and Ethosomes for Increased Brain Drug Bioavailability
Patrícia C. Pires, Ana Cláudia Paiva‐Santos, Francisco Veiga
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1424-1424
Open Access | Times Cited: 17
Nanoengineered immune check point inhibitors delivery for targeted brain cancer treatment: Current status and future perspectives
Juan Liu, Yichao Wang, Zhidu Song, et al.
Biochemical Pharmacology (2025) Vol. 233, pp. 116789-116789
Closed Access
Editorial: New insights into intracellular pathways and therapeutic targets in CNS diseases
Lisa Gherardini
Frontiers in Cellular Neuroscience (2025) Vol. 19
Open Access
Advanced particulate carrier-mediated technologies for nasal drug delivery
Vivek P. Chavda, Gargi Jogi, Nirav Shah, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 74, pp. 103569-103569
Closed Access | Times Cited: 26
Neural stem cells for Parkinson’s disease management: Challenges, nanobased support, and prospects
Tuba Öz, Ajeet Kaushik, Małgorzata Kujawska
World Journal of Stem Cells (2023) Vol. 15, Iss. 7, pp. 687-700
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top